The Ambition
To Cure.

Disruptive
Targets.

Transformational
Medicines.

Our Vision

The Ambition To Cure

Tackling the toughest challenges in medicine with the aspiration to cure human diseases.

Disruptive Targets

Leveraging our CRISPRomics® platform to discover the genome’s top therapeutic targets with curative potential.

Transformational Medicines

Advancing our pipeline of CRISPR/Cas9-engineered Tumor Infiltrating Lymphocytes (eTIL®) programs and our partnered first-in-class candidates for the treatment of cancer.